Latest News & Updates

Breaking News

  • 10 minutes ago

  • Pharma Now Editorial Team

Allogene Advances Dual-Target CAR T Strategy in Multiple Myeloma
Breaking News
BioMed X Deploys AI-Integrated Team for Bispecific Antibody R&D in France

Pharma Now Editorial Team

Other trending news you may like to read

Allogene Advances Dual-Target CAR T Strategy in Multiple Myeloma

Allogene publishes preclinical data on an allogeneic BCMA/CD70 dual CAR T construct targeting high-risk multiple myeloma.

Pharma Now Editorial Team

Pharma Now

BioMed X Deploys AI-Integrated Team for Bispecific Antibody R&D in France

BioMed X launches an AI-driven bispecific antibody team in France, led by immunologist Tomabu Adjobimey.

Pharma Now Editorial Team

Pharma Now

Eastern Caribbean Stewardship Workshop Targets Antimicrobial Misuse

The Ministry of Health and OECS convene a multidisciplinary antimicrobial stewardship workshop targeting responsible medicine use across the Eastern Caribbean.

Pharma Now Editorial Team

Pharma Now

Zongertinib Frontline Data Signal Scale-Up Demands for HER2 NSCLC

Updated zongertinib frontline data in HER2-mutated NSCLC show durable activity, raising manufacturing scale-up and process validation questions.

Pharma Now Editorial Team

Pharma Now